Cargando…
Efficiency Evaluation of Neuroprotection for Therapeutic Hypothermia to Neonatal Hypoxic-Ischemic Encephalopathy
Background: To evaluate the safety and neurological outcomes of therapeutic hypothermia to neonatal hypoxic-ischemic encephalopathy (HIE). Materials and Methods: Medical records of 61 neonates with moderate to severe HIE were retrospectively enrolled and divided into a therapeutic hypothermia group...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505668/ https://www.ncbi.nlm.nih.gov/pubmed/34650397 http://dx.doi.org/10.3389/fnins.2021.668909 |
_version_ | 1784581581431635968 |
---|---|
author | Weng, Bowen Yan, Chongbing Chen, Yihuan Gong, Xiaohui Cai, Cheng |
author_facet | Weng, Bowen Yan, Chongbing Chen, Yihuan Gong, Xiaohui Cai, Cheng |
author_sort | Weng, Bowen |
collection | PubMed |
description | Background: To evaluate the safety and neurological outcomes of therapeutic hypothermia to neonatal hypoxic-ischemic encephalopathy (HIE). Materials and Methods: Medical records of 61 neonates with moderate to severe HIE were retrospectively enrolled and divided into a therapeutic hypothermia group (n = 36) and conventional therapy group (n = 25). Results: No significant difference in the incidence of severe adverse events was found between the two groups. Minimum and maximum voltages of amplitude-integrated electroencephalography (aEEG) recording results showed statistically significant differences in therapeutic hypothermia group after 72 h. The neonatal behavioral neurological assessment (NBNA) on the 28th day after birth and Bayley Scales of Infant Development, second edition (BSID II) scores at 18 months old were significant higher in the therapeutic hypothermia group than the conventional therapy group. Conclusion: Therapeutic hypothermia for neonates with moderate to severe HIE improved the development of the nervous system in 0–18-month-old infants and showed a predominant role in reducing death and major neuron development-associated disabilities. |
format | Online Article Text |
id | pubmed-8505668 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85056682021-10-13 Efficiency Evaluation of Neuroprotection for Therapeutic Hypothermia to Neonatal Hypoxic-Ischemic Encephalopathy Weng, Bowen Yan, Chongbing Chen, Yihuan Gong, Xiaohui Cai, Cheng Front Neurosci Neuroscience Background: To evaluate the safety and neurological outcomes of therapeutic hypothermia to neonatal hypoxic-ischemic encephalopathy (HIE). Materials and Methods: Medical records of 61 neonates with moderate to severe HIE were retrospectively enrolled and divided into a therapeutic hypothermia group (n = 36) and conventional therapy group (n = 25). Results: No significant difference in the incidence of severe adverse events was found between the two groups. Minimum and maximum voltages of amplitude-integrated electroencephalography (aEEG) recording results showed statistically significant differences in therapeutic hypothermia group after 72 h. The neonatal behavioral neurological assessment (NBNA) on the 28th day after birth and Bayley Scales of Infant Development, second edition (BSID II) scores at 18 months old were significant higher in the therapeutic hypothermia group than the conventional therapy group. Conclusion: Therapeutic hypothermia for neonates with moderate to severe HIE improved the development of the nervous system in 0–18-month-old infants and showed a predominant role in reducing death and major neuron development-associated disabilities. Frontiers Media S.A. 2021-09-28 /pmc/articles/PMC8505668/ /pubmed/34650397 http://dx.doi.org/10.3389/fnins.2021.668909 Text en Copyright © 2021 Weng, Yan, Chen, Gong and Cai. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Weng, Bowen Yan, Chongbing Chen, Yihuan Gong, Xiaohui Cai, Cheng Efficiency Evaluation of Neuroprotection for Therapeutic Hypothermia to Neonatal Hypoxic-Ischemic Encephalopathy |
title | Efficiency Evaluation of Neuroprotection for Therapeutic Hypothermia to Neonatal Hypoxic-Ischemic Encephalopathy |
title_full | Efficiency Evaluation of Neuroprotection for Therapeutic Hypothermia to Neonatal Hypoxic-Ischemic Encephalopathy |
title_fullStr | Efficiency Evaluation of Neuroprotection for Therapeutic Hypothermia to Neonatal Hypoxic-Ischemic Encephalopathy |
title_full_unstemmed | Efficiency Evaluation of Neuroprotection for Therapeutic Hypothermia to Neonatal Hypoxic-Ischemic Encephalopathy |
title_short | Efficiency Evaluation of Neuroprotection for Therapeutic Hypothermia to Neonatal Hypoxic-Ischemic Encephalopathy |
title_sort | efficiency evaluation of neuroprotection for therapeutic hypothermia to neonatal hypoxic-ischemic encephalopathy |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505668/ https://www.ncbi.nlm.nih.gov/pubmed/34650397 http://dx.doi.org/10.3389/fnins.2021.668909 |
work_keys_str_mv | AT wengbowen efficiencyevaluationofneuroprotectionfortherapeutichypothermiatoneonatalhypoxicischemicencephalopathy AT yanchongbing efficiencyevaluationofneuroprotectionfortherapeutichypothermiatoneonatalhypoxicischemicencephalopathy AT chenyihuan efficiencyevaluationofneuroprotectionfortherapeutichypothermiatoneonatalhypoxicischemicencephalopathy AT gongxiaohui efficiencyevaluationofneuroprotectionfortherapeutichypothermiatoneonatalhypoxicischemicencephalopathy AT caicheng efficiencyevaluationofneuroprotectionfortherapeutichypothermiatoneonatalhypoxicischemicencephalopathy |